Clinical Laboratory Improvement Amendments
Scope
Date
~
-
Tech, Media & Telecom
S.Korea's KT CS reports record sales in 2022
On Friday, KT Corp.'s customer service unit, KT CS, announced that its sales revenue for the previous year reached a record high of 591.6 billion wo...
Feb 17, 2023 (Gmt+09:00)
-
Logistics
S.Korea's Kakao Enterprise introduces Matching 2.0 strategy
Kakao Enterprise, a leading IT platform business operator in South Korea, recently announced its "Matching 2.0" strategy to enhance the quality of s...
Feb 17, 2023 (Gmt+09:00)
-
Robotics
LG Elec places GuideBot in museums to improve viewing accessibility
LG Electronics Inc. announced on Thursday that the LG CLOi GuideBot "Qi" will be deployed as a curator at both the Gongju National Museum and Nation...
Feb 16, 2023 (Gmt+09:00)
-
Energy
SK Ecoplant enters bioenergy sector with waste-to-fuel tech
South Korea's SK Ecoplant Co. will supply fuel made from the conversion of food waste.The company on Thursday said it entered the bioenergy market a...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem builds S.Korea's first plant for clinical trials
LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...
Feb 14, 2023 (Gmt+09:00)
-
ECM/DCM
S.Korean listed companies' cancelled shares reach $8.6 bn over past 3 years
South Korea's listed companies have cancelled 11 trillion won ($8.6 billion) worth of shares over the past three years.The Korea Exchange said on Su...
Feb 13, 2023 (Gmt+09:00)
-
Earnings
S.Korea game sector remains in dark after poor earnings
South Korea’s game publishers reported dismal quarterly earnings, deepening concerns over their outlook this year amid doubts over measures su...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Foreign exchange
S.Korea-Australia renew $8.1 bn currency swap deal for 5 years
The Bank of Korea (BOK) and the Australian Central Bank have agreed to extend the valid date of the current Australian dollar/won currency swap cont...
Feb 07, 2023 (Gmt+09:00)
-
Artificial intelligence
Online portal Naver to release AI-powered search chatbot in H1
South Korean online portal giant Naver Corp. is set to launch a beta version of Search GPT, an artificial intelligence-powered search service, in th...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio's diagnostic products start to be used in clinical tests in Vietnam
South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Pre-IPOs
PIF, GIC to invest $964 mn in Korea's Kakao Entertainment
Saudi Arabia’s Public Investment Fund (PIF) and Singapore’s sovereign wealth fund GIC have agreed to invest a combined $964 million in K...
Jan 12, 2023 (Gmt+09:00)
-
Korean chipmakers
SK Hynix introduces AI solution to semiconductor process
SK Hynix Inc. said on Tuesday that it has started to improve production efficiency and yield by introducing an artificial intelligence (AI) solution...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...
Jan 10, 2023 (Gmt+09:00)
-
Artificial intelligence
S-1 calls AI video solutions core of this year's AI security market
Access management of facial recognition needs the most improvement this year and artificial intelligence (AI)-based solutions such as intelligent cl...
Jan 10, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
DSME puts welding collaborative robots into field
Daewoo Shipbuilding & Marine Engineering Co. (DSME) said on Monday that it developed a collaborative robot, or cobot, that welds pipes in the ...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Electric vehicles
LS Cable abandons round wire to focus on higher-value EV wire
LS Cable & System Ltd. has decided to give up the round wire business to concentrate on higher-value-added products used in electric vehicles (E...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Pension funds
NPS will intensify shareholder engagement, new CIO says
Seo Won-joo, the new chief investment officer of the National Pension Service (NPS) of South Korea, said on Dec. 27 that the pension fund will stren...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand